One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Urine, doctors, and the acanthocyte’s 30th birthday
DanielKraus1HansKöhler2JuliaWeinmann-Menke1
The changing role of glucocorticoids in the treatment of anti–neutrophil cytoplasmic antibody–associated vasculitis
NeerajDhaun12Stephen P.McAdoo34
Running interference: lumasiran and other RNA interference therapeutics for kidney diseases
Ziad A.Massy12Tilman B.Drueke1
Untangling the fibers of sarcopenia: activin A in chronic kidney disease–associated muscle wasting
Andrew S.Terker1T. AlpIkizler1
Murine models of uremic cardiomyopathy as a necessary tool to unravel mechanisms involved in cardiorenal syndrome
José AlbertoNavarro-GarcÃa12GemaRuiz-Hurtado13
Insights into vitamin K metabolism in chronic kidney disease: more complicated than kale deficiency
Jennifer S.Lees12Patrick B.Mark12
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine
LauraObici1VittorioBellotti23
Addressing screams for evidence on renoprotection by GLP-1 receptor agonists
TakayoshiSasako1ToshimasaYamauchi1
BLISS-LN trial revisited: function matters
SarahGleeson1LizLightstone12
Uremic encephalopathy
Mitchell H.Rosner1FaeqHusain-Syed2ThiagoReis34ClaudioRonco56RaymondVanholder7
The lupus nephritis management renaissance
Juan M.Mejia-Vilet1AnaMalvar2ArnonArazi3Brad H.Rovin4
A systematic review and meta-analysis of murine models of uremic cardiomyopathy
JosefinSoppert114JaninaFrisch214JuliaWirth1ChristianHemmers1PeterBoor34RafaelKramann4SonjaVondenhoff1JuliaMoellmann5MichaelLehrke5MathiasHohl6Emiel P.C.van der Vorst178910ChristianWerner6ThimoteusSpeer11ChristophMaack12NikolausMarx5JoachimJankowski17Leticia PratesRoma2HeidiNoels113
Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy
AlexandraCambier12345613Patrick J.Gleeson12345LiliaAbbad12345FannyCanesi12345Jenniferda Silva12345JulieBex-Coudrat12345GeorgesDeschênes16OliviaBoyer17MarionRabant18TimUlinski9JulienHogan16MichelPeuchmaur110LaurelineBerthelot11Renato C.Monteiro1234512
Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies
ZhengziYi110FadiSalem210Madhav C.Menon13KarenKeung45CaixiaXi1SebastianHultin4M. RizwanHaroon Al Rasheed2LiLi2FeiSu1ZeguoSun1ChengguoWei1WeiqingHuang1SamuelFredericks1QishengLin3KhadijaBanu3GermaineWong4Natasha M.Rogers4SamiraFarouk1…WeijiaZhang1
Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich �-2 glycoprotein-1
QuanHong126HongCai136LuZhang14ZhengzheLi1FangZhong1ZhaohuiNi3GuangyanCai2Xiang-MeiChen2John CijiangHe15KyungLee1
Dephosphorylation of AMP-activated protein kinase exacerbates ischemia/reperfusion-induced acute kidney injury via mitochondrial dysfunction
HaijianMa16XiaozhenGuo26ShichaoCui26YongmeiWu3YangmingZhang24XiaoyanShen1CenXie2JingyaLi25
RNA-based immunoglobulin repertoire sequencing is a new tool for the management of monoclonal gammopathy of renal (kidney) significance
VincentJavaugue12910VirginiePascal23910SébastienBender29SarahNasraddine3MathildeDargelos19MehdiAlizadeh4AlexisSaintamand5MatthieuFilloux3PacoDerouault6SabrinaBouyer7EstelleDesport19ArnaudJaccard289FrankBridoux129MichelCogné259ChristopheSirac29
Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease
NadineKaesler12FelixSchreibing12ThimoteusSpeer34Sofia de laPuente-Secades5NikolasRapp6ChristianeDrechsler7NazaninKabgani2ChristophKuppe12PeterBoor18VeraJankowski5LeonSchurgers126RafaelKramann12910JürgenFloege110
A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis
JakubSikora1213TerezaKmochová113DitaMušálková113MichalPohludka1PetrPřikryl3HanaHartmannová1KateřinaHodaňová1HelenaTrešlová1LenkaNosková1LenkaMrázová1ViktorStránecký1MariiaLunová4MilanJirsa45EvaHonsová26SurendraDasari7Ellen D.McPhail8NelsonLeung9MartinaŽivná1…StanislavKmoch110
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
YangXu126Edouard L.Fu236Catherine M.Clase4FaizanMazhar2Meg J.Jardine5Juan J.Carrero2
A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease
Jiun-RueyHu110LeslieMyint210Andrew S.Levey3JosefCoresh45Lesley A.Inker3Morgan E.Grams456EliseoGuallar45Kasper D.Hansen57Eugene P.Rhee8TariqShafi9
Prediction models of treatment response in lupus nephritis
IsabelleAyoub15Bethany J.Wolf25LinyuGeng3HuijuanSong1AasthaKhatiwada4Betty P.Tsao3Jim C.Oates3Brad H.Rovin1
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis
MaximeEspi1211XavierCharmetant111ThomasBarba134CyrilleMathieu1CarolinePelletier5LaetitiaKoppe24ElodieChalencon2EmilieKalbacher5VirginieMathias16AnneOvize7EmmanuelleCart-Tanneur7ChristineBouz7LaurencePellegrina7EmmanuelMorelon48LaurentJuillard45DenisFouque24CécileCouchoud910OlivierThaunat148
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
Brad H.Rovin1RichardFurie2Y.K. OnnoTeng3GabrielContreras4AnaMalvar5XueqingYu6BeulahJi7YuliaGreen7TaniaGonzalez-Rivera810DamonBass8JenniferGilbride9Chun-HangTang9David A.Roth8
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
SamKant1AntoineAzar2DuvuruGeetha1
Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis
AndreasKronbichler1Se YongJung2Min SeoKim3Jae IlShin4
Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression
ThomasStehlé12PhilippeGrimbert12PhilippeRemy12AnissaMoktefi13VincentAudard12KhalilEl Karoui12
Lipoic acid in neural epidermal growth factor-like 1–associated membranous nephropathy: more than a coincidence?
Tiffany N.Caza1Christopher P.Larsen1
Sema4A-Nrp1 versus Sema4A-plexinB2 in the acutely damaged kidney
AmélieCalmont1
KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease
VivianFonseca1TakujiKohzuma2Rodolfo J.Galindo3CyrusDeSouza4
The authors reply:
M. LuizaCaramori1Katherine R.Tuttle2NikhilTandon3David J.Tunnicliffe45Ian H.de Boer2PeterRossing67
Corrigendum to Cai J, Liu Z, Huang X, et al. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression Kidney Int. 2020;97:106–118
Diagnosis of AApoAIV medullary amyloidosis at radical nephrectomy
Paul E.Rosenstiel1TahiraAlves2
Acute methotrexate-induced crystal nephropathy
Matthew F.Blum1Mohamed G.Atta1
Noninvasive screening of vancomycin-associated cast nephropathy
CédricRafat1JeremyZaworski2YosuLuque12MichelDaudon3AliceDoreille1LaurentMesnard12EmmanuelLetavernier23
The Case | An unusual cause of renal vascular thrombi after kidney transplantation
PaulineErpicum127StéphanieGrosch137CatherineBonvoisin1AntoineBouquegneau1LaurentWeekers1LucRadermacher4FrançoisJouret12MarieLejeune5OlivierHougrand6ChristopheBovy13
